6,218 followers
Integrin avb6-targeting remaining in the news, a de-risked target now, and showing promise in an array of indications
Integrin avb6-targeting remaining in the news, a de-risked target now, and showing promise in an array of indications
New research: In vivo evaluation of integrin αvβ6-targeting peptide in NSCLC and brain metastasis: Introduction Integrin αvβ6, which is upregulated in malignancies and remains absent or weak in normal tissue, is a promising target in molecular… https://t.